University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease

dc.contributor.authorSaadati, Hassan
dc.contributor.authorBaradaran, Hamid Reza
dc.contributor.authorDanaei, Goodarz
dc.contributor.authorOstovar, Afshin
dc.contributor.authorHadaegh, Farzad
dc.contributor.authorJanani, Leila
dc.contributor.authorSteyerberg, Ewout W.
dc.contributor.authorKhalili, Davood
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2021-01-04T12:01:01Z
dc.date.available2021-01-04T12:01:01Z
dc.date.issued2020-11-04
dc.descriptionAcknowledgements This study was conducted at the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences Tehran, Iran. Lown Scholar Program of the Harvard T.H. Chan School of Public Health helped in funding and designing the study. We thank the respectful staff of the Non-Communicable Diseases Office of the Ministry of Health and Medical Education in Iran for their help and advice on developing the survey. We gratefully thank Prof. MA Puhan for sharing their experience on the design and implementation of best-worst scaling. Funding This study is a part of a project funded by the National Institute of Medical Research. Development (NIMAD) (Grant No. 964114) and was supported by the Iran University of Medical. Sciences. The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.en
dc.description.statusPeer revieweden
dc.format.extent11
dc.format.extent1150250
dc.identifier184949098
dc.identifier85cb285f-a4c1-4527-8cad-64a1730b313e
dc.identifier85094957074
dc.identifier33148227
dc.identifier.citationSaadati, H, Baradaran, H R, Danaei, G, Ostovar, A, Hadaegh, F, Janani, L, Steyerberg, E W & Khalili, D 2020, 'Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease', BMC Medical Informatics and Decision Making, vol. 20, 288. https://doi.org/10.1186/s12911-020-01304-wen
dc.identifier.doi10.1186/s12911-020-01304-w
dc.identifier.issn1472-6947
dc.identifier.otherORCID: /0000-0002-5070-5864/work/86449867
dc.identifier.urihttps://hdl.handle.net/2164/15582
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85094957074&partnerID=8YFLogxKen
dc.identifier.vol20en
dc.language.isoeng
dc.relation.ispartofBMC Medical Informatics and Decision Makingen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectBenefit harm outcomesen
dc.subjectCardiovascular diseaseen
dc.subjectPreferencesen
dc.subjectPrimary preventionen
dc.subjectStatinsen
dc.subjectR Medicineen
dc.subjectHealth Policyen
dc.subjectHealth Informaticsen
dc.subjectOtheren
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleIranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular diseaseen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Saadati_IranianGeneralPopulationsAndHealthCareProviders_VOR.pdf
Size:
1.1 MB
Format:
Adobe Portable Document Format

Collections